Granules India gets USFDA nod for allergy treatment drug

Granules India said it has received approval for Fexofenadine Hydrochloride tablets. The approved product is bio-equivalent to the reference listed drug product (RLD), Allegra Allergy Tablets, 60 mg and 180 mg, of Sanofi-Aventis US LLC.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/2W3sJGL
via IFTTT